Jaleel Shujath

Jaleel is an Industry Strategist in Life Sciences for OpenText, based near Washington DC.
Analytics

Real world evidence: a concept whose time has come?

The 21st Century Cures Act, passed by the US Congress late last year, marks a hugely significant moment for the…

Read More »
Digital Transformation

Quality and innovation from bench to clinic: the role of integrated quality management

In my previous blog I looked at the role of data integrity. In this blog, I’d like to focus on…

Read More »
Analytics

Quality and Innovation From Bench to Clinic – the Role of Data Integrity

According to a recent PwC survey of pharma CEOs, 35% consider strengthening innovation a top priority. At the same time,…

Read More »
Compliance

Clarity First. Clarity Always – Managing Marketing Content in the Life Sciences

Marketing from the Life Sciences industry is constantly under the spotlight. US state and federal governments have handed out some…

Read More »
Enterprise Content Management

Documentum and OpenText for Life Sciences – Moving Beyond FUD

Now that a couple of months have passed since the ink dried on the OpenText deal for Dell EMC’s Enterprise…

Read More »
Compliance

Regulatory Matters: Collaboration is key for Life (Sciences) in 2017 – Part Two

The Life Sciences sector is very innovative. The Boston Consulting Group found that almost 20% of the world’s most innovative…

Read More »
Compliance

Regulatory Matters: Collaboration is key for Life (Sciences) in 2017 – Part One

Life Sciences, like life itself, is constantly evolving. The rigid, product-based environment of complementary but discrete healthcare specialists is rapidly…

Read More »
Digital Transformation

Digital Disruption is here! What are you doing about it?

dis·rup·tion ( disˈrəpSH(ə)n/) – disturbance or problems that interrupt an event, activity, or process. There’s a whole new conversation happening…

Read More »
Business Network

Regulatory Matters: The Year Ahead in Life Sciences

As I began to write this article to prognosticate on the year ahead, I recalled a Ladies’ Home Journal article…

Read More »
Business Network

Regulatory Matters: What you should know about new FDA Supply ChainSecurity regulations

Last week, the European Medicines Agency sent warning letters to healthcare professionals across Europe about falsified and/or tampered vials of…

Read More »
Business Network

Regulatory Matters – The Life Sciences EIM Blog

Life science companies, such as pharmaceutical, biotech, diagnostic, food quality, and cosmetic, operate in a highly regulated and rapidly evolving…

Read More »
Compliance

Big Data and Information Governance in Life Sciences

The clamor around big data’s applications and how best to tame them was one of the key themes which emerged…

Read More »